These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 31271468)

  • 1. Antiphospholipid syndrome: a clinical review.
    Mezhov V; Segan JD; Tran H; Cicuttini FM
    Med J Aust; 2019 Aug; 211(4):184-188. PubMed ID: 31271468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiphospholipid syndrome: still an enigma.
    Chaturvedi S; McCrae KR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of patients with the antiphospholipid syndrome.
    Alving BM
    J Thromb Thrombolysis; 2001 Sep; 12(1):89-93. PubMed ID: 11711694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary antiphospholipid syndrome].
    Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R
    Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiphospholipid antibodies--risk factors for venous thromboembolism and arterial thrombosis].
    Zawilska K
    Pol Arch Med Wewn; 2007; 117 Suppl():41-5. PubMed ID: 18778019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Italian Registry of Antiphospholipid Antibodies.
    Finazzi G
    Haematologica; 1997; 82(1):101-5. PubMed ID: 9107095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis.
    Wahl DG; Bounameaux H; de Moerloose P; Sarasin FP
    Arch Intern Med; 2000 Jul; 160(13):2042-8. PubMed ID: 10888978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic risk in the antiphospholipid syndrome.
    Lim W
    Semin Thromb Hemost; 2014 Oct; 40(7):741-6. PubMed ID: 25299926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiphospholipid antibodies, lupus anticoagulant and thrombosis].
    Capel P
    Rev Med Brux; 1997 Jun; 18(3):108-10. PubMed ID: 9273597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pathogenesis, diagnosis and treatment of antiphospholipid syndrome].
    Ohmura K; Oku K; Atsumi T
    Nihon Rinsho; 2014 Jul; 72(7):1309-13. PubMed ID: 25163327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical manifestations and management of the antiphospholipid syndrome.
    Derksen RH
    Lupus; 1996 Apr; 5(2):167-9. PubMed ID: 8743135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies.
    Gabrielli F; Alcini E; Di Prima MA; Mazzacurati G; Masala C
    Int J Cardiol; 1995 Sep; 51(2):117-26. PubMed ID: 8522406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies in pediatrics.
    Quintero-Del-Rio AI
    Curr Rheumatol Rep; 2002 Oct; 4(5):387-91. PubMed ID: 12217242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of antiphospholipid antibodies.
    Petri M
    Rheum Dis Clin North Am; 1994 May; 20(2):443-69. PubMed ID: 8016420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid syndrome.
    Gezer S
    Dis Mon; 2003 Dec; 49(12):696-741. PubMed ID: 14679358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of very high risk pregnancy with secondary anti-phospholipid syndrome and triple positivity to the anti-phospholipid antibodies.
    Rose HL; Ho WK
    J Thromb Thrombolysis; 2014 Nov; 38(4):453-6. PubMed ID: 24777280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.